Takanari Jun, Nakahigashi Jun, Sato Atsuya, Waki Hideaki, Miyazaki Shogo, Uebaba Kazuo, Hisajima Tatsuya
Amino Up Chemical Co., Ltd.
J Nutr Sci Vitaminol (Tokyo). 2016;62(3):198-205. doi: 10.3177/jnsv.62.198.
The aim of this study was to examine the effectiveness of Enzyme-Treated Asparagus Extract (ETAS) on improving stress response. A randomized, double-blind, placebo-controlled cross-over trial was undertaken in healthy volunteers. ETAS (150 mg/d) or a placebo was consumed for 28 d, with a washout period. Psychological parameters were examined using a self-report scale questionnaire and psychological stress was applied using the Uchida-Kraepelin (U-K) test. During the stress load, autonomic nervous function was analyzed. After the stress load, a profile of mood states (POMS) psychological rating was performed, and serum cortisol, plasma catecholamine, salivary secretory immunoglobulin A (sIgA), and salivary cortisol were analyzed. ETAS intake improved the self-reported rating for the items "Feel tired," "Hard to get up," and "Feel heavy" in the psychological questionnaire; ameliorated the self-reported rating for the items "Depression-Dejection" and "Fatigue" in the POMS questionnaire; and increased salivary sIgA levels after the U-K test. In contrast, serum and salivary cortisol levels, and plasma catecholamine did not change. During the U-K test, ETAS significantly upregulated the sympathetic nerve activity. Furthermore, ETAS intake significantly increased the number of answers and the number of correct answers in the U-K test, suggesting that it might improve office work performance with swiftness and accuracy under stressful conditions. In conclusion, ETAS supplementation reduced feelings of dysphoria and fatigue, ameliorated quality of sleep, and enhanced stress-load performance as well as promoted stress response by increasing salivary sIgA levels. These data suggest ETAS intake may exert beneficial effects, resulting from well-controlled stress management, in healthy individuals.
本研究旨在探讨酶处理芦笋提取物(ETAS)对改善应激反应的有效性。在健康志愿者中进行了一项随机、双盲、安慰剂对照的交叉试验。受试者服用ETAS(150毫克/天)或安慰剂28天,期间有洗脱期。使用自我报告量表问卷检查心理参数,并使用内田-克雷佩林(U-K)测验施加心理压力。在应激负荷期间,分析自主神经功能。应激负荷后,进行情绪状态剖面图(POMS)心理评分,并分析血清皮质醇、血浆儿茶酚胺、唾液分泌型免疫球蛋白A(sIgA)和唾液皮质醇。摄入ETAS改善了心理问卷中“感到疲倦”、“难以起床”和“感到沉重”项目的自我报告评分;改善了POMS问卷中“抑郁-沮丧”和“疲劳”项目的自我报告评分;并在U-K测验后提高了唾液sIgA水平。相比之下,血清和唾液皮质醇水平以及血浆儿茶酚胺没有变化。在U-K测验期间,ETAS显著上调交感神经活动。此外,摄入ETAS显著增加了U-K测验中的答题数量和正确答案数量,表明它可能在压力条件下提高办公工作的速度和准确性。总之,补充ETAS可减轻烦躁和疲劳感,改善睡眠质量,增强应激负荷表现,并通过提高唾液sIgA水平促进应激反应。这些数据表明,在健康个体中,摄入ETAS可能通过良好控制的压力管理产生有益影响。